Post by
Canada2016 on May 31, 2021 10:22am
Buy Out
With end of June looming I wonder if my pre conference buy out theory will come to fruition with the SP bleeding and management not caring to Mr. Fifty shades of Gray Dom accepting a new position with MRS. I don't know regardless end of June will be big. My expectations 7 patients fully enrolled and news from 3 patients insulin independent. And it's been forever kicking tires on a licensing deal. And better not be options announced at AGM without one.
Comment by
BioTeck on May 31, 2021 12:46pm
When you are putting out 1 NR per year, I think you have some cycles to work another job. I hope Sernova isn't paying him what MRS is. Don't hold your breath for a buyout. Short of a potential deal, everything else is already baked into the price. Unusual uptick on low volume today. Maybe we can blame the americans for keeping down the stock price.
Comment by
Metalsguy1 on May 31, 2021 6:15pm
wait a minute...It has been a while since I looked at who's who on the company website but there is no mention of a clinical director now and there was one before. I remember someone mentioning the name here once. A woman if I recall correctly, I had the impression sometime ago that she was the star who was helping refine the pouch. Perhaps the well connected pumpers can enlighten us.
Comment by
BioTeck on May 31, 2021 8:36pm
Maybe it was Delphina who was exercising her options and selling? Would she still be an insider if she had already quit before exercising? Not sure. The fact that Dominic quit because Phil wouldn't tell him anything is a plus in books. Sernova has a history of leaking info.
Comment by
BioTeck on Jun 01, 2021 10:36am
"Key people jumping ship ( or are they being pushed? ) before important trajectory in the company's history is not comforting." Hopefully being pushed and being replaced with more skilled staff. Now if only we'd get some kind of news to spell things out for us...
Comment by
Metalsguy1 on May 31, 2021 6:03pm
put down the crack pipe Canada.